A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy, Hyperalgesia

In brief

The purpose of this study is to determine the effects of NGX426 on intradermal capsaicin induced pain in hyperalgesia.

Key facts

Study ID

NCT00832546

Run by

TorreyPines Therapeutics

People needed

18

Starts

2008-05-01

Expected to finish

2008-09-01

Last updated by the study team

2009-01-30

Who can join

Age: 21 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy males, age 21-55

You may not qualify if…

• Allergy to study drug

Where it is running

• University of California — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.